Clinical Trial

Ketogenic Diet in MASLD-related cACLD

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The investigators hypothesize that very low ketogenic diet could represent a new therapeutic option in the management of patients with MASLD and cACLD. Therefore, the investigator propose a randomized controlled study that evaluates the impact of two dietary protocols -Mediterranean diet, and very low ketogenic diet- the MD and the VLCKD, in individuals with cACLD secondary to MASLD.
Trial Details
NCT Number NCT06537466
Lead Sponsor University of Palermo
Conditions Steatohepatitis, Nonalcoholic, Steatosis of Liver, Cirrhosis, Liver
Enrollment 50 participants
Start Date 2024-11
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2024-08-05